Pamela Trillo Aliaga

10PUBLICATIONS
11CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 29, 2025
Management of MET-Driven Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer.

Panagiotis Agisilaos Angelopoulos, Antonio Passaro, Ilaria Attili

|Jun 27, 2025
HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs-A Long Way to the Top.

Pamela Trillo Aliaga, Gianluca Spitaleri, Ilaria Attili

|Sep 27, 2024
Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario.

Valeria Fuorivia, Ilaria Attili, Carla Corvaja

|Aug 10, 2024
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis.

Ilaria Attili, Riccardo Asnaghi, Davide Vacirca

|Jul 27, 2024
Post-Progression Analysis of EGFR-Mutant NSCLC Following Osimertinib Therapy in Real-World Settings.

Ilaria Attili, Carla Corvaja, Gianluca Spitaleri

Pageof 2